Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

被引：0

作者：

Park, S. H. ^{[1
]}

Amissi, S. ^{[1
]}

Algara-Suarez, P. ^{[1
]}

Gong, D. S. ^{[1
]}

Mroueh, A. ^{[1
]}

Belcastro, E. ^{[1
]}

Matsushita, K. ^{[1
]}

Bruckert, C. ^{[1
]}

Chaker, A. B. ^{[1
]}

Jesel, L. ^{[2
]}

Ohlmann, P. ^{[2
]}

Morel, O. ^{[2
]}

Mazzucotelli, J. P. ^{[2
]}

Schini-Kerth, V. B. ^{[1
]}

机构：

[1] Univ Strasbourg, INSERM UMR 1260, Regenerat Nanomed, Strasbourg, France

[2] Univ Hosp Strasbourg, Cardiol, Strasbourg, France

来源：

EUROPEAN HEART JOURNAL | 2021年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3440 / 3440

页数：1

共 50 条

[21] First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases
Dziewiecka, Ewa
Winiarczyk, Mateusz
Gliniak, Matylda
Kaciczak, Monika
Wisniowska-Smialek, Sylwia
Karabinowska, Aleksandra
Holcman, Katarzyna
Kostkiewicz, Magdalena
Hlawaty, Marta
Lesniak-Sobelga, Agata
Podolec, Piotr
Rubis, Pawel
CARDIOLOGY JOURNAL, 2020, 27 (05) : 639 - 641
[22] Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
Yurista, Salva R.
Sillje, Herman H. W.
Rienstra, Michiel
de Boer, Rudolf A.
Westenbrink, B. Daan
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[23] CAN PATIENTS ON SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS SAFELY RECEIVE A UROLOGIC IMPLANT?
Prebay, Zachary
Foss, Halle
Ebbott, David
Hyman, Jason
Li, Michael
Chung, Paul
JOURNAL OF UROLOGY, 2023, 209 : E865 - E865
[24] Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
D'Onofrio, Nunzia
Sardu, Celestino
Trotta, Maria Consiglia
Scisciola, Lucia
Turriziani, Fabrizio
Ferraraccio, Franca
Panarese, Iacopo
Petrella, Lella
Fanelli, Mara
Modugno, Piero
Massetti, Massimo
Marfella, Ludovica Vittoria
Sasso, Ferdinando Carlo
Rizzo, Maria Rosaria
Barbieri, Michelangela
Furbatto, Fulvio
Minicucci, Fabio
Mauro, Ciro
Federici, Massimo
Balestrieri, Maria Luisa
Paolisso, Giuseppe
Marfella, Raffaele
MOLECULAR METABOLISM, 2021, 54
[25] Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
Salva R. Yurista
Herman H. W. Silljé
Michiel Rienstra
Rudolf A. de Boer
B. Daan Westenbrink
Cardiovascular Diabetology, 19
[26] Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
Tatsumi, Tomoaki
Oshitari, Toshiyuki
Takatsuna, Yoko
Ishibashi, Ryoichi
Koshizaka, Masaya
Shiko, Yuki
Baba, Takayuki
Yokote, Koutaro
Yamamoto, Shuichi
LIFE-BASEL, 2022, 12 (05):
[27] How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients
Adnan Zaina
Nunzia Prencipe
Elena Golden
Alessandro Maria Berton
Eldad Arad
Ali Abid
Jeryes Shehadeh
Sameer Kassem
Ezio Ghigo
Endocrine, 2023, 80 : 491 - 499
[28] A Study to Evaluate the Effect of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors on Oxidative Stress Parameters in Type 2 Diabetes Mellitus Patients
Sharma, Ankita
Aruna, D.
Beatrice, Anne
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
[29] A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition
Basile, Jan
POSTGRADUATE MEDICINE, 2011, 123 (04) : 38 - 45
[30] Author response to: Acute abdomen as a side-effect of sodium-glucose co-transporter 2 inhibitors in diabetic patients
Kietaibl, Antonia-Therese
Fasching, Peter
Glaser, Karl
Petter-Puchner, Alexander H.
BRITISH JOURNAL OF SURGERY, 2022, 109 (04) : E68 - E68

← 1 2 3 4 5 →